TROV – Float 3 million. Market cap 18 million. Short interest 6%. Volume 7 million. Trovagene is a clinical-stage oncology therapeutics company, using a precision medicine predictive biomarker approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers. The stock is trading up 26% today. Watch for continuation on day 2 w/ sustained volume.
MXC – Float <1 million. Market cap 10 million. Short interest 5%. Volume 328K. No recent news, but two green days in a row and now approaching multi-month breakout. Will keep on close watch for sustained (or increase in volume) + true breakout.
Join now or log in to leave a comment